EUVIMEDEUVIMED entdecken
Multizentrische Studie

Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients

Alexander von Spreckelsen iD, Trine Kjær iD, Marcel Reimann iD, Christian Torp-Pedersen iD, Mikkel Porsborg Andersen iD, Gianni Virgili iD, Augusto Azuara-Blanco iD, Dorte Gyrd-Hansen iD, Miriam Kolko iD

Acta Ophthalmologica · 2025

DOI: 10.1111/aos.70047 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Alexander von Spreckelsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Intraocular Pressure, Patient Preference, Antihypertensive Agents, Ocular Hypertension. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Dansk Glaukom Forening (The Danish Glaucoma Association), Frimodt-Heineke Fonden, Dagmar Marshalls Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Assessment of patient preferences for local adverse effects (AEs) of intraocular pressure (IOP)‐lowering eye drops.

Methods

A total of 10 000 eye drop‐treated patients aged 40–75 years were sampled from the Danish national registries. A discrete choice experiment (DCE) was distributed to each patient to elicit preferences for distinct levels of five representative local AE attributes of IOP‐lowering drops: acute discomfort, persistent discomfort, blurred vision, non‐persistent cosmetic changes, and persistent cosmetic changes. Preference weights were computed using conditional logistic regression and normalised using profile‐based normalisation. The mildest severity levels were used as a reference. Heterogeneity analyses were conducted across patient covariates to examine variation in preference patterns.

Results

A total of 2445 patients (24% response rate; 55% male; median age: 67 years) completed the DCE, with 2096 providing additional covariate data. 95% reported a diagnosis of glaucoma or ocular hypertension. More females than males reported currently experiencing AEs (48% vs. 35%). 25% had previously discontinued treatment with IOP‐lowering eye drops due to AEs. The DCE revealed significant differences in the patients' preferences for avoiding AEs. Severe blurred vision, persistent cosmetic changes, and persistent discomfort exhibited the highest levels of disutility. Moderate acute discomfort and non‐persistent cosmetic changes were least important. The patients' preferences varied notably by age and gender.

Conclusion

This study provides novel insight into patients' preferences for AEs of IOP‐lowering eye drops by identifying the characteristics that most strongly influence treatment choices. These insights support future clinical studies and shared decision‐making, facilitating personalised care that can improve adherence, quality of life, and long‐term patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intraocular PressurePatient PreferenceAntihypertensive AgentsOcular HypertensionGlaucomaChoice BehaviorHumansMaleFemaleAgedMiddle AgedOphthalmic SolutionsDenmarkAdultSurveys and QuestionnairesRegistries

Stichwörter der Autor:innen

adverse effectsintraocular pressure lowering medicationocular hypertensionopen‐angle glaucomapatient preferences

Substanzen

Ophthalmic SolutionsAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Ophthalmology, Copenhagen University Hospital, Glostrup, Denmark.
  • Department of Public Health, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Cardiology, Nordsjaellands Hospital (North Zealand Hospital), Hilleroed, Denmark.
  • The Prehospital Center, Naestved, Denmark.

ORCID-Profile: Alexander von Spreckelsen, Trine Kjær, Marcel Reimann, Christian Torp-Pedersen, Mikkel Porsborg Andersen, Gianni Virgili, Augusto Azuara-Blanco, Dorte Gyrd-Hansen, Miriam Kolko

Förderung

  • Dansk Glaukom Forening (The Danish Glaucoma Association)
  • Frimodt-Heineke Fonden
  • Dagmar Marshalls Fond

Zitieren

APA

von Spreckelsen, A., Kjær, T., Reimann, M., Torp-Pedersen, C., Porsborg Andersen, M., Virgili, G., Azuara-Blanco, A., Gyrd-Hansen, D., & Kolko, M. (2025). Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients. Acta Ophthalmologica. https://doi.org/10.1111/aos.70047

Vancouver

von Spreckelsen A, Kjær T, Reimann M, Torp-Pedersen C, Porsborg Andersen M, Virgili G, et al. Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients. Acta Ophthalmologica. 2025. doi:10.1111/aos.70047

BibTeX
@article{vonSpreckelsen2025,
  author = {von Spreckelsen, Alexander and Kjær, Trine and Reimann, Marcel and Torp-Pedersen, Christian and Porsborg Andersen, Mikkel and Virgili, Gianni and Azuara-Blanco, Augusto and Gyrd-Hansen, Dorte and Kolko, Miriam},
  title = {Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients},
  journal = {Acta Ophthalmologica},
  year = {2025},
  doi = {10.1111/aos.70047}
}
Kostenlos starten →